Bridgewater Associates’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-32,881
Closed -$381K 775
2024
Q3
$381K Sell
32,881
-36,167
-52% -$341K ﹤0.01% 710
2024
Q2
$521K Sell
69,048
-6,599
-9% -$54.6K ﹤0.01% 752
2024
Q1
$759K Sell
75,647
-12,821
-14% -$119K ﹤0.01% 589
2023
Q4
$823K Sell
88,468
-24,147
-21% -$250K ﹤0.01% 659
2023
Q3
$1.43M Sell
112,615
-159,734
-59% -$2.19M 0.01% 555
2023
Q2
$3.87M Sell
272,349
-14,185
-5% -$199K 0.02% 351
2023
Q1
$4.27M Buy
286,534
+166,920
+140% +$2.53M 0.03% 338
2022
Q4
$1.78M Sell
119,614
-17,517
-13% -$286K 0.01% 550
2022
Q3
$2.26M Sell
137,131
-117,084
-46% -$2.36M 0.01% 537
2022
Q2
$5.34M Buy
254,215
+129,933
+105% +$2.65M 0.02% 467
2022
Q1
$2.92M Buy
124,282
+31,548
+34% +$772K 0.01% 600
2021
Q4
$2.52M Buy
92,734
+13,624
+17% +$365K 0.01% 427
2021
Q3
$2.25M Sell
79,110
-3,427
-4% -$104K 0.01% 421
2021
Q2
$2.49M Buy
+82,537
New +$2.44M 0.02% 450
2019
Q2
Sell
-28,491
Closed -$774K 348
2019
Q1
$774K Buy
+28,491
New +$955K ﹤0.01% 259
2016
Q2
Sell
-7,732
Closed -$500K 359
2016
Q1
$500K Buy
+7,732
New +$513K 0.01% 240
2015
Q4
Sell
-8,534
Closed -$655K 362
2015
Q3
$655K Buy
+8,534
New +$689K 0.01% 294

Other funds holding MD

Bridgewater Associates's MD Position: Q4 2024 in Review

Bridgewater Associates sold out of Pediatrix Medical (MD) in Q4 2024, closing a stake of 32,881 shares — an estimated $381K sold.

Bridgewater Associates first reported a position in MD in Q3 2015 and held it in 17 quarters. The position peaked at $5.34M in Q2 2022. 229 funds tracked by Wall St. Rank hold MD as of Q4 2024.

  • Bridgewater Associates reported no remaining Pediatrix Medical position as of Q4 2024 after selling out during the quarter.
  • Bridgewater Associates sold 32,881 Pediatrix Medical shares in Q4 2024, an estimated $381K.
  • Bridgewater Associates first reported a position in Pediatrix Medical in Q3 2015 and held it in 17 quarters.
  • Bridgewater Associates's Pediatrix Medical position peaked at $5.34M in Q2 2022.
  • 229 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2024.

Based on Bridgewater Associates's 13F filing for Q4 2024, filed 13 Feb 2025.